CAMP4 Therapeutics Corp’s filing revealed that its 10% Owner 5AM Partners VI, LLC acquired Company’s shares for reported $4.5 million on Sep 11 ’25. In the deal valued at $1.53 per share,2,941,176 shares were bought. As a result of this transaction, 5AM Partners VI, LLC now holds 2,941,176 shares worth roughly $7.79 million.
Then, Polaris Management Co. VII, L. bought 1,307,189 shares, generating $1,999,999 in total proceeds. Upon buying the shares at $1.53, the 10% Owner now owns 2,825,500 shares.
Before that, Nashat Amir bought 1,307,189 shares. CAMP4 Therapeutics Corp shares valued at $1,999,999 were divested by the Director at a price of $1.53 per share. As a result of the transaction, Nashat Amir now holds 2,825,500 shares, worth roughly $7.49 million.
Wedbush initiated its CAMP4 Therapeutics Corp [CAMP] rating to an Outperform in a research note published on May 27, 2025; the price target was $8. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in early November with a ‘”an Outperform”‘ rating. Piper Sandler began covering CAMP with “an Overweight” recommendation on November 05, 2024. JP Morgan started covering the stock on November 05, 2024. It rated CAMP as “an Overweight”.
Price Performance Review of CAMP
On Monday, CAMP4 Therapeutics Corp [NASDAQ:CAMP] saw its stock fall -18.46% to $2.65. Over the last five days, the stock has gained 60.61%. Nevertheless, the stocks have fallen -49.23% over the past one year.
How much short interest is there in CAMP4 Therapeutics Corp?
A steep rise in short interest was recorded in CAMP4 Therapeutics Corp stocks on 2025-08-29, dropping by 29241.0 shares to a total of 0.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 0.25 million shares. There was a decline of -13.39%, which implies that there is a negative sentiment for the stock.
